Nav1.8
(Redirected from SCN10A)
[edit | edit source]
Nav1.8, also known as sodium channel, voltage-gated, type X, alpha subunit (SCN10A), is a voltage-gated sodium channel that is primarily expressed in peripheral neurons. It plays a crucial role in the generation and conduction of action potentials in nociceptive neurons, which are responsible for the sensation of pain.
Structure[edit | edit source]
Nav1.8 is composed of an alpha subunit that forms the pore of the channel. The alpha subunit is a large transmembrane protein that consists of four homologous domains (I-IV), each containing six transmembrane segments (S1-S6). The S4 segment acts as the voltage sensor, while the S5 and S6 segments form the pore through which sodium ions pass. The intracellular loops between the domains are important for channel gating and modulation.
Function[edit | edit source]
Nav1.8 is unique among sodium channels due to its resistance to tetrodotoxin (TTX), a potent sodium channel blocker. This property allows Nav1.8 to continue functioning in conditions where other sodium channels are inhibited. Nav1.8 is activated at more depolarized membrane potentials compared to other sodium channels, which makes it particularly important in the transmission of pain signals under pathological conditions.
Expression[edit | edit source]
Nav1.8 is predominantly expressed in small-diameter dorsal root ganglion (DRG) neurons and trigeminal ganglion neurons. These neurons are involved in the transmission of nociceptive information from the periphery to the central nervous system. The expression of Nav1.8 can be upregulated in response to nerve injury or inflammation, contributing to chronic pain states.
Clinical Significance[edit | edit source]
Mutations in the SCN10A gene, which encodes the Nav1.8 channel, have been associated with various pain disorders. Gain-of-function mutations can lead to increased pain sensitivity, while loss-of-function mutations may result in reduced pain perception. Nav1.8 is a target for the development of new analgesic drugs aimed at treating chronic pain conditions without affecting normal sensory functions.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD